Skip to main content

SERA PROGNOSTICS, INC.

For the period ended Dec 31, 2024. Filed Mar 19, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 19, 2025

SERA$2.19+5.3%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
Special Note Regarding Forward-Looking Statements3
PART I
Item 1.Business4
Item 1A.Risk Factors42
Item 1B.Unresolved Staff Comments85
Item 1C.Cybersecurity85
Item 2.Properties86
Item 3.Legal Proceedings86
Item 4.Mine Safety Disclosures86
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities87
Item 6.[ Reserved ]87
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations88
Item 7A.Quantitative and Qualitative Disclosures About Market Risk97
Item 8.Financial Statements and Supplementary Data98
Item 9.Changes in and Disagreements With Accountants on Accounting and Financial Disclosure124
Item 9A.Controls and Procedures124
Item 9B.Other Information124
Item 9C.Disclosure Regarding Foreign Jurisdiction that Prevent Inspections125
PART III
Item 10.Directors, Executive Officers and Corporate Governance126
Item 11.Executive Compensation126
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters126
Item 13.Certain Relationships and Related Transactions, and Director Independence126
Item 14.Principal Accounting Fees and Services126
PART IV
Item 15.Exhibits and Financial Statement Schedules127
Signatures130

“Sera,” “PreTRM,” “The Pregnancy Company” and our logo are our trademarks. All other service marks, trademarks, and trade names appearing in this Annual Report on Form 10-K for the fiscal year ended December 31, 2024, or the Annual Report, are the property of their respective owners. We do not intend our use or display of other companies’ trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies. Solely for convenience, trademarks and tradenames referred to in this Annual Report may appear without the ® or ™ symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and tradenames. Unless the context otherwise requires, we use the terms “Sera,” “Company,” “we,” “us” and “our” in this Annual Report to refer to Sera Prognostics, Inc.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.